|
Video: What is a Stock Split?
|
|
Organogenesis Holdings is a regenerative medicine company engaged on the development, manufacture and commercialization of solutions for the Advanced Wound Care and Surgical and Sports Medicine markets. In the Advanced Wound Care market, Co. engages on the development and commercialization of a portfolio of cellular and acellular wound care offerings that treat patients from the earliest indication of impaired healing to wound closure. In the Surgical and Sports Medicine market, Co. engages on the development and commercialization of products that support the healing of musculoskeletal injuries, including chronic degenerative conditions such as osteoarthritis and tendonitis. According to our Organogenesis Holdings stock split history records, Organogenesis Holdings has had 0 splits. | |
|
Organogenesis Holdings (ORGO) has 0 splits in our Organogenesis Holdings stock split history database.
Looking at the Organogenesis Holdings stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Organogenesis Holdings shares, starting with a $10,000 purchase of ORGO, presented on a split-history-adjusted basis factoring in the complete Organogenesis Holdings stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
01/06/2017 |
|
End date: |
03/27/2024 |
|
Start price/share: |
$9.75 |
|
End price/share: |
$2.76 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-71.69% |
|
Average Annual Total Return: |
-16.03% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$2,831.59 |
|
Years: |
7.22 |
|
|
|
|
|